Richard P. Ramonell

1.7k total citations
24 papers, 216 citations indexed

About

Richard P. Ramonell is a scholar working on Physiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard P. Ramonell has authored 24 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard P. Ramonell's work include Asthma and respiratory diseases (8 papers), COVID-19 Clinical Research Studies (6 papers) and Allergic Rhinitis and Sensitization (5 papers). Richard P. Ramonell is often cited by papers focused on Asthma and respiratory diseases (8 papers), COVID-19 Clinical Research Studies (6 papers) and Allergic Rhinitis and Sensitization (5 papers). Richard P. Ramonell collaborates with scholars based in United States. Richard P. Ramonell's co-authors include Merin Kuruvilla, F. Eun-Hyung Lee, Imran H. Iftikhar, Colin Swenson, Joshua M. Levy, Igñacio Sanz, Christopher M. Tipton, Sarah K. Wise, F. Eun‐Hyung Lee and Alexander F. Rosenberg and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and CHEST Journal.

In The Last Decade

Richard P. Ramonell

18 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard P. Ramonell United States 8 107 80 75 62 40 24 216
Agamemnon Bakakos Greece 7 134 1.3× 16 0.2× 96 1.3× 45 0.7× 32 0.8× 21 182
Yi‐Ke Deng China 8 71 0.7× 94 1.2× 59 0.8× 33 0.5× 52 1.3× 10 262
Hirotaka Yasuba Japan 8 151 1.4× 38 0.5× 93 1.2× 50 0.8× 70 1.8× 29 244
Hristo Metev Bulgaria 3 133 1.2× 17 0.2× 79 1.1× 129 2.1× 23 0.6× 4 276
Sarah Dudley United Kingdom 5 147 1.4× 23 0.3× 98 1.3× 103 1.7× 42 1.1× 5 271
A. Carsin France 9 82 0.8× 40 0.5× 202 2.7× 43 0.7× 64 1.6× 33 353
Kugathasan Mutalithas United Kingdom 6 295 2.8× 119 1.5× 279 3.7× 59 1.0× 88 2.2× 9 426
Maria Adelaide Calderazzo Italy 6 40 0.4× 88 1.1× 203 2.7× 51 0.8× 8 0.2× 13 345
Mark Thong Singapore 11 28 0.3× 73 0.9× 47 0.6× 46 0.7× 38 0.9× 33 295
Emma Rubenstein France 5 55 0.5× 37 0.5× 87 1.2× 10 0.2× 8 0.2× 11 186

Countries citing papers authored by Richard P. Ramonell

Since Specialization
Citations

This map shows the geographic impact of Richard P. Ramonell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Ramonell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Ramonell more than expected).

Fields of papers citing papers by Richard P. Ramonell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Ramonell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Ramonell. The network helps show where Richard P. Ramonell may publish in the future.

Co-authorship network of co-authors of Richard P. Ramonell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Ramonell. A scholar is included among the top collaborators of Richard P. Ramonell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Ramonell. Richard P. Ramonell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramonell, Richard P., Timothy B. Oriss, Nicholas J. Brandon, et al.. (2025). CD8+ TEMRAs in severe asthma associate with asthma symptom duration and escape proliferation arrest. JCI Insight. 10(8).
2.
Kosters, Astrid, Victoria Murray, Gurjot Gill, et al.. (2024). Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19. Science Translational Medicine. 16(772). eadq1789–eadq1789. 5 indexed citations
3.
Ramonell, Richard P., et al.. (2024). CARDIAC COMPLICATIONS FOLLOWING UNINTENTIONAL MOLNUPIRAVIR OVERDOSE: A CASE REPORT. CHEST Journal. 166(4). A1856–A1857.
5.
Ramonell, Richard P., et al.. (2024). Development of rheumatoid arthritis in patients with asthma: A case series. The Journal of Allergy and Clinical Immunology In Practice. 13(3). 692–694.e2. 1 indexed citations
6.
Yang, Amy, et al.. (2024). Persistent Lung Eosinophilia While on Benralizumab. A5304–A5304.
7.
Ramonell, Richard P., Matthew C. Woodruff, Joshua M. Levy, et al.. (2023). Single-cell analysis of human nasal mucosal IgE antibody secreting cells reveals a newly minted phenotype. Mucosal Immunology. 16(3). 287–301. 18 indexed citations
8.
Ray, Anuradha, et al.. (2023). Bridging the Gap between Innate and Adaptive Immunity in the Lung: Summary of the Aspen Lung Conference 2022. American Journal of Respiratory Cell and Molecular Biology. 69(3). 266–280.
9.
Yang, Junkai, Astrid Kosters, Ximo Pechuan-Jorge, et al.. (2022). Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load. Blood Advances. 7(5). 778–799. 19 indexed citations
10.
Haddad, Natalie S., Sophia Nozick, Colleen S. Kraft, et al.. (2022). Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection. Journal of Clinical Microbiology. 60(3). e0220121–e0220121. 6 indexed citations
11.
Bassit, Leda, Joshua D. Chandler, Natalie S. Haddad, et al.. (2022). Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies. ImmunoHorizons. 6(2). 144–155. 5 indexed citations
12.
Ramonell, Richard P., et al.. (2021). Pilot Study of a Novel Gelatin-Based Model for Venovenous Extracorporeal Membrane Oxygenation Cannula Insertion Simulation. ATS Scholar. 2(3). 297–303. 1 indexed citations
13.
Ramonell, Richard P., et al.. (2021). Longitudinal trends using a point-of-care gelatin-based model for ultrasound-guided central venous catheter insertion. Medical Education Online. 26(1). 1924350–1924350. 1 indexed citations
14.
Kyu, Shuya, Richard P. Ramonell, Merin Kuruvilla, et al.. (2021). Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells. PLoS ONE. 16(11). e0259644–e0259644. 3 indexed citations
15.
Corrado, Alessia, Richard P. Ramonell, Matthew C. Woodruff, et al.. (2021). Extrafollicular IgD+ B cells generate IgE antibody secreting cells in the nasal mucosa. Mucosal Immunology. 14(5). 1144–1159. 32 indexed citations
16.
Ramonell, Richard P., et al.. (2021). Checklists Improve Team Performance During Simulated Extracorporeal Membrane Oxygenation Emergencies: A Randomized Trial. Critical Care Explorations. 3(4). e0404–e0404. 6 indexed citations
17.
Wong, An-Kwok Ian, Anand Shah, Melissa Lyle, et al.. (2020). Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019. Critical Care Explorations. 2(12). e0288–e0288. 1 indexed citations
18.
Ramonell, Richard P., F. Eun-Hyung Lee, Joshua M. Levy, & Merin Kuruvilla. (2020). Exhaled nitric oxide measurements are not influenced by anti-eosinophil therapy in patients with asthma. Annals of Allergy Asthma & Immunology. 126(1). 102–104. 12 indexed citations
19.
Ramonell, Richard P. & Imran H. Iftikhar. (2020). Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis. Lung. 198(1). 95–103. 24 indexed citations
20.
Ramonell, Richard P., F. Eun-Hyung Lee, Colin Swenson, & Merin Kuruvilla. (2019). Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 742–743. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026